Panel Discussion: Ensuring Orthogonal Validation of Unintentional Edits

Time: 10:00 am
day: Conference Day Two


  • Benchmarking the benefits and limitations of key sequencing and PCR tools for determining on- and off-target editing outcomes
  • Assessing the latest technologies for detecting on- and off-targets
  • Case studies of effective use of NGS in the clinical setting
  • How do I effectively combine a range of these assays for a robust orthogonal approach?